AAAAAA

   
Results: 1-12 |
Results: 12
ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER
Authors: UENO NT RONDON G MIRZA NQ GEISLER DK ANDERLINI P GIRALT SA ANDERSSON BS CLAXTON DF GAJEWSKI JL KHOURI IF KORBLING M MEHRA RC PRZEPIORKA D RAHMAN Z SAMUELS BI VANBESIEN K HORTOBAGYI GN CHAMPLIN RE
Citation: Nt. Ueno et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(3), 1998, pp. 986-993
BONE-MARROW TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANT FOR NON-HODGKINS-LYMPHOMA
Authors: DELIMA M VANBESIEN KW GIRALT SA KHOURI IF MEHRA R ANDERSSON BS PRZEPIORKA D GAJEWSKI JL KORBLING M CHAMPLIN RE
Citation: M. Delima et al., BONE-MARROW TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANT FOR NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 19(2), 1997, pp. 121-127
MANAGEMENT OF LYMPHOMA RECURRENCE AFTER ALLOGENEIC TRANSPLANTATION - THE RELEVANCE OF GRAFT-VERSUS-LYMPHOMA EFFECT
Authors: VANBESIEN KW DELIMA M GIRALT SA MOORE DF KHOURI IF RONDON G MEHRA R ANDERSSON BS DYER C CLEARY K PRZEPIORKA D GAJEWSKI JL CHAMPLIN RE
Citation: Kw. Vanbesien et al., MANAGEMENT OF LYMPHOMA RECURRENCE AFTER ALLOGENEIC TRANSPLANTATION - THE RELEVANCE OF GRAFT-VERSUS-LYMPHOMA EFFECT, Bone marrow transplantation, 19(10), 1997, pp. 977-982
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA - RESPONSE, TOXICITY, AND SURVIVAL DEPEND ON DISEASE HISTOLOGY
Authors: VANBESIEN KW MEHRA RC GIRALT SA KANTARJIAN HM PUGH WC KHOURI IF MOON Y WILLIAMS P ANDERSSON BS PRZEPIORKA D MCCARTHY PL GAJEWSKI JL DEISSEROTH AB CABANILLAS FF CHAMPLIN R
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA - RESPONSE, TOXICITY, AND SURVIVAL DEPEND ON DISEASE HISTOLOGY, The American journal of medicine, 100(3), 1996, pp. 299-307
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT
Authors: VANBESIEN KW KHOURI IF GIRALT SA MCCARTHY P MEHRA R ANDERSSON BS PRZEPIORKA D GAJEWSKI JL BELLARE N NATH R ROMAGUERA JE MCLAUGHLIN P KORBLING M DEISSEROTH AB CABANILLAS FF CHAMPLIN RE
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT, Journal of clinical oncology, 13(5), 1995, pp. 1096-1102
ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Authors: GIRALT SA LEMAISTRE CF VRIESENDORP HM ANDERSSON BS DIMOPOULOS M GAJEWSKI J VANBESIEN K MEHRA R PRZEPIORKA D KHOURI I YAU J KANTARJIAN H DEISSEROTH AB CHAMPLIN RE
Citation: Sa. Giralt et al., ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 12(9), 1994, pp. 1923-1930
AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS
Authors: KHOURI IF KEATING MJ VRIESENDORP HM READING CL PRZEPIORKA D HUH YO ANDERSSON BS VANBESIEN KW MEHRA RC GIRALT SA IPPOLITI C MARSHALL M THOMAS MW OBRIEN S ROBERTSON LE DEISSEROTH AB CHAMPLIN RE
Citation: If. Khouri et al., AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS, Journal of clinical oncology, 12(4), 1994, pp. 748-758
LEUKEMIA RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REVIEW
Authors: GIRALT SA CHAMPLIN RE
Citation: Sa. Giralt et Re. Champlin, LEUKEMIA RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REVIEW, Blood, 84(11), 1994, pp. 3603-3612
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT
Authors: VANBESIEN KW KHOURI IF GIRALT SA MCCARTHY P MEHRA R ANDERSSON BS PRZEPIORKA D GAJEWSKI JL BELLARE N NATH R ROMAGUERA JE MCLAUGHLIN PW KORBLING M DEISSEROTH AB CABANILLAS FF CHAMPLIN RE
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT, Blood, 84(10), 1994, pp. 10000205-10000205
EFFECTIVENESS OF AN ORAL TRIAZOLE FOR OPPORTUNISTIC MOLD INFECTIONS IN PATIENTS WITH CANCER - EXPERIENCE WITH SCH-39304
Authors: ANAISSIE EJ KONTOYIANNIS DP VARTIVARIAN S KANTARJIAN HM OBRIEN S GIRALT SA ANDERSSON BS KARL C CHAMPLIN RE BODEY GP
Citation: Ej. Anaissie et al., EFFECTIVENESS OF AN ORAL TRIAZOLE FOR OPPORTUNISTIC MOLD INFECTIONS IN PATIENTS WITH CANCER - EXPERIENCE WITH SCH-39304, Clinical infectious diseases, 17(6), 1993, pp. 1022-1031
ACUTE LYMPHOID LEUKEMIA MOLECULAR PHENOTYPE IN A PATIENT WITH BENIGN-PHASE CHRONIC MYELOGENOUS LEUKEMIA
Authors: GUO JQ HIRSCHGINSBERG CF XIAN YM STASS SA CHAMPLIN RE GIRALT SA MCCREDIE KB CAMPBELL ML ARLINGHAUS RB
Citation: Jq. Guo et al., ACUTE LYMPHOID LEUKEMIA MOLECULAR PHENOTYPE IN A PATIENT WITH BENIGN-PHASE CHRONIC MYELOGENOUS LEUKEMIA, Hematologic pathology, 7(2), 1993, pp. 91-106
EFFECT OF PRIOR INTERFERON-ALFA THERAPY ON THE OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: GIRALT SA KANTARJIAN HM TALPAZ M RIOS MB DELGIGLIO A ANDERSSON BS PRZEPIORKA D DEISSEROTH AB CHAMPLIN RE
Citation: Sa. Giralt et al., EFFECT OF PRIOR INTERFERON-ALFA THERAPY ON THE OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 11(6), 1993, pp. 1055-1061
Risultati: 1-12 |